Session

IBD epidemiology and drug safety

INCREASED INCIDENCE OF CANCER AND MORTALITY IN A PEDIATRIC-ONSET IBD POPULATION-BASED COHORT OF 1344 PATIENTS DIAGNOSED BETWEEN 1988 AND 2011: THE INSPIRED STUDY

Ariane Leroyer, Claire Dupont-Lucas, Delphine Ley, Dominique Turck, Guillaume Savoye, Claire Spyckerelle, Valerie Bertrand, Vincent Maunoury, Nathalie Guillon, Mathurin Fumery, Corinne Gower-Rousseau

INCREASED INCIDENCE OF CANCER AND MORTALITY IN A PEDIATRIC-ONSET IBD POPULATION-BASED COHORT OF 1344 PATIENTS DIAGNOSED BETWEEN 1988 AND 2011: THE INSPIRED STUDY

Claire Dupont-Lucas

NEW THERAPEUTIC STRATEGIES HAVE CHANGED THE NATURAL HISTORY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASES: RESULTS FROM A POPULATION-BASED COHORT OVER A 24-YEAR PERIOD (1988-2011)

Ariane Leroyer, Claire Dupont, Valerie Bertrand, Claire Spyckerelle, Guillaume Savoye, Mathurin Fumery, Hélène Sarter, Nathalie Guillon, Corinne Gower-Rousseau, Benjamin Pariente, Delphine Ley, Dominique Turck

NEW THERAPEUTIC STRATEGIES HAVE CHANGED THE NATURAL HISTORY OF PAEDIATRIC INFLAMMATORY BOWEL DISEASES: RESULTS FROM A POPULATION-BASED COHORT OVER A 24-YEAR PERIOD (1988-2011)

Delphine Ley

SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTION LTE LONG-TERM EXTENSION STUDY

Stefan Schreiber, Mamoru Watanabe, Ulrik Moerch, Gerhard Rogler, Edward V Loftus Jr, Jeremy Hsieh, Yan Zhou, Sally Zhao, Chohee Yun

SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTION LTE LONG-TERM EXTENSION STUDY

Stefan Schreiber

THE RISK OF ACUTE ARTERIAL EVENTS ASSOCIATED WITH ANTI-TNF AND AZATHIOPRINE IN INFLAMMATORY BOWEL DISEASES: A DANISH NATIONWIDE COHORT STUDY

Daniel Ward, Mikael Andersson, Kristine Højgaard Allin, Nynne Nyboe Andersen, Julien Kirchgesner, Laurent Beaugerie, Tine Jess

THE RISK OF ACUTE ARTERIAL EVENTS ASSOCIATED WITH ANTI-TNF AND AZATHIOPRINE IN INFLAMMATORY BOWEL DISEASES: A DANISH NATIONWIDE COHORT STUDY

Daniel Ward

USTEKINUMAB LEVELS IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE AND NEONATES EXPOSED IN-UTERO

Ralley Prentice, Emma Flanagan, Emily Wright, Katerina V. Kiburg, Peter R. Gibson, Alyson Ross, Sally J. Bell, Ourania Rosella

USTEKINUMAB LEVELS IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE AND NEONATES EXPOSED IN-UTERO

Ralley Prentice

Item 1 - 10 / 10
1